Efficacy of lenalidomide in myelodysplastic/myeloproliferative neoplasms with ring sideroblasts and an extreme platelet count

Lenalidomide is efficient in reducing red blood cell transfusion dependency and markedly lowering platelet counts in MDS/MPN‐RS‐T in the context of major platelet counts.

Detalles Bibliográficos
Autores principales: Divoux, Marion, Plocque, Alexia, Sevin, Margaux, Voillat, Laurent, Feugier, Pierre, Guerci‐Bresler, Agnès, Girodon, Francois, Broséus, Julien
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7495870/
https://www.ncbi.nlm.nih.gov/pubmed/32983494
http://dx.doi.org/10.1002/ccr3.3026

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7495870/
https://www.ncbi.nlm.nih.gov/pubmed/32983494
http://dx.doi.org/10.1002/ccr3.3026

Ejemplares similares